MedTrace Logo

Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

NCT02914236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-05-21

Study results available
· View outcomes & findings →

Summary

Evaluation of the Aerin Medical Device used for the treatment of nasal obstruction.

Conditions

  • Nasal Obstruction

Interventions

DEVICE

Vivaer Stylus

Delivery of low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area

Sponsors & Collaborators

  • Aerin Medical

    lead INDUSTRY

Principal Investigators

  • Scott Wolf, MD · Aerin Medical

  • Ofer Jacobowitz, MD, PhD · Mount Sinai Hospital, New York, NY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-27
Primary Completion
2017-07-21
Completion
2017-08-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02914236 on ClinicalTrials.gov